Literature DB >> 18656616

The search for cancer stem cells in hepatocellular carcinoma.

Yukio Kamohara1, Naotsugu Haraguchi, Koshi Mimori, Fumiaki Tanaka, Hiroshi Inoue, Masaki Mori, Takashi Kanematsu.   

Abstract

BACKGROUND: Recent evidence suggests that some solid cancers originate from cancer stem cells. We have identified a subset of candidate stem cells, which are termed side population (SP) cells, in the hepatocellular carcinoma cell line Huh7. Because most stem cells reside in the G0 phase of the cell cycle, G0 cells were isolated, and the relationship between SP cells and G0 cells was investigated to clarify the biological characteristics of G0 cells.
METHODS: Huh7 cells were sorted using Hoechst 33342 and Pyronin Y. The cells were then divided into G0, G1, and G2/M fractions and cultured under low-attachment conditions to obtain cellular spheres. Tumorigenetic ability was investigated using subcutaneous transplantation to NOD/SCID mice. G0 and G1 cells were analyzed for markers indicative of hepatocytic (albumin expression) and cholangiocytic (keratin 19 expression) differentiation and DNA synthesis (Ki67).
RESULTS: The cell-cycle distribution of cultured Huh7 cells was 0.7% (G0), 63.8% (G1), and 34.5% (G2/M, S). The G0 cells were located within the neck of the SP fraction. The G0 cells showed spheroid formation and 3-dimensional growth. Those cells showed marked tumorigenesis in NOD/SCID transplantation. G0 cells, which did not express Ki67, were weakly positive for expression of albumin and were clearly positive for the expression of keratin 19. In contrast, G1 cells were positive for Ki67 and albumin expression but negative for keratin 19.
CONCLUSION: G0 cells are present in the SP fraction of Huh7. They show self-renewal, tumorigenesis, and bidirectional lineage. These findings suggest that the G0 cells within the Huh7 cell line are promising candidates as cancer stem cells for future studies of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18656616     DOI: 10.1016/j.surg.2008.04.008

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  13 in total

Review 1.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

Review 2.  Strategies for isolating and enriching cancer stem cells: well begun is half done.

Authors:  Jiang-Jie Duan; Wen Qiu; Sen-Lin Xu; Bin Wang; Xian-Zong Ye; Yi-Fang Ping; Xia Zhang; Xiu-Wu Bian; Shi-Cang Yu
Journal:  Stem Cells Dev       Date:  2013-05-09       Impact factor: 3.272

Review 3.  Stem cell origins and animal models of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli; Clifford J Steer; M Behnan Sahin; Erik N K Cressman
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

4.  TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population.

Authors:  M R Loebinger; E K Sage; D Davies; S M Janes
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

5.  Side populations from cervical-cancer-derived cell lines have stem-cell-like properties.

Authors:  Jairo Villanueva-Toledo; Alberto Ponciano-Gómez; Elizabeth Ortiz-Sánchez; Efraín Garrido
Journal:  Mol Biol Rep       Date:  2014-01-14       Impact factor: 2.316

6.  Hepatospheres: Three dimensional cell cultures resemble physiological conditions of the liver.

Authors:  Franziska van Zijl; Wolfgang Mikulits
Journal:  World J Hepatol       Date:  2010-01-27

7.  Ex vivo hepatic venography for hepatocellular carcinoma in livers explanted for liver transplantation.

Authors:  Kensuke Miyazaki; Akihiko Soyama; Masaaki Hidaka; Koji Hamasaki; Kosho Yamanouchi; Mitsuhisa Takatsuki; Takashi Kanematsu; Susumu Eguchi
Journal:  World J Surg Oncol       Date:  2011-09-27       Impact factor: 2.754

8.  Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway.

Authors:  Alexandra Drakaki; Maria Hatziapostolou; Christos Polytarchou; Christina Vorvis; George A Poultsides; John Souglakos; Vassilis Georgoulias; Dimitrios Iliopoulos
Journal:  BMC Cancer       Date:  2015-07-24       Impact factor: 4.430

9.  Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.

Authors:  Ihab Shafek Atta
Journal:  Histol Histopathol       Date:  2021-07-13       Impact factor: 2.303

10.  Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.

Authors:  Younghun Jung; Ann M Decker; Jingcheng Wang; Eunsohl Lee; Lulia A Kana; Kenji Yumoto; Frank C Cackowski; James Rhee; Peter Carmeliet; Laura Buttitta; Todd M Morgan; Russell S Taichman
Journal:  Oncotarget       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.